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Summary
Plant expression systems have proven to be exceptional in producing high-value complex
polymeric proteins such as secretory IgAs (SIgAs). However, polymeric protein production
requires the expression of multiple genes, which can be transformed as single or multiple T-DNA
units to generate stable transgenic plant lines. Here, we evaluated four strategies to stably
transform multiple genes and to obtain high expression of all components. Using the in-seed
expression of a simplified secretory IgA (sSIgA) as a reference molecule, we conclude that it is
better to spread the genes over two T-DNAs than to contain them in a single T-DNA, because of
the presence of homologous recombination events and gene silencing. These T-DNAs can be
cotransformed to obtain transgenic plants in one transformation step. However, if time permits,
more transformants with high production levels of the polymeric protein can be obtained either
by sequential transformation or by in-parallel transformation followed by crossing of transfor-
mants independently selected for excellent expression of the genes in each T-DNA.
Introduction
Secretory immunoglobulin A (SIgA) is a heterodecameric Ig of
400 kDa that is predominantly involved in the protection of the
mucosal surfaces against pathogenic infections. Application of
pathogen-specific SIgAs at the mucosal surfaces can provide
immediate protection (Corthesy, 2010) but requires bulk
amounts of the SIgA protein in the range of gram amounts
per day and per patient. However, recombinant manufacturing
of SIgA has been challenging because of its complex assembly.
SIgA is composed of two monomeric IgAs (mIgAs) each made
up of two heavy and two light chains, a joining (J-)chain
keeping the two mIgAs together in a dimeric IgA (dIgA), and
the secretory component (SC), wrapped around the dIgA. Of
the expression systems evaluated, plants have been shown to
be the most successful platform for SIgAs (Ariaans et al., 2014;
Ma et al., 1995). The bacterial and yeast systems currently do
not efficiently secrete assembled Igs, and the levels of correctly
post-transcriptionally modified SIgAs are too low (Fischer et al.,
2004; Vasilev et al., 2016). Also the few milligram production
levels of SIgAs attained in mammalian or insect cell fermenters
are not sufficient or cost effective to be translated into the
clinic. In contrast, several different SIgAs have been expressed
successfully in plants, and one of these SIgAs, that is, CaroRx,
has been approved for use as medical device for dental care
(Paul and Ma, 2011).
Plant-made SIgAs can be produced either via transient expres-
sion or after stable genomic integration. The transient expression
system has allowed successful extraction of SIgAs against
rotavirus from leaves of Nicotiana benthamiana already five days
post-infiltration (Juarez et al., 2013) and its production capacity
has been thoroughly validated, for instance, with the production
of millions of vaccine doses in a month against H1N1 VLP
influenza by the company Medicago (D’Aoust et al., 2010).
However, for passive immunization applications, we believe that
stable transformation is the most suited system for the cheap
production of SIgA in plants because of the ease of scalability
through the already established infrastructure of commercial
varieties, the inheritable expression and the possibility to produce
the recombinant protein in specific compartments and tissues,
such as seeds, with advantageous properties (Stoger et al., 2014;
Virdi et al., 2015). To obtain stably transformed SIgA-producing
plants, several strategies have been described. The first is the
Nicotiana tabacum SIgA-producing line obtained by sequentially
crossing individual transformants with, the heavy chain, light
chain, J-chain and SC encoding genes (Ma et al., 1995). High
SIgA levels were obtained, but three sequential crossings were
needed to generate the stably transformed line containing the
four different loci in homozygous condition. Using a single T-DNA
system in which all the four components required for SIgA
production are clustered, significantly reduces the time to develop
SIgA-producing stable transformants as shown for Lemna (duck-
weed; Ariaans et al., 2014) and Arabidopsis thaliana (Arabidop-
sis; Nakanishi et al., 2017). However, the cloning process of this
single T-DNA can be challenging because of the large size of the
construct. Previously, we evaluated a third strategy, which is
based on the simultaneous cotransformation of all T-DNAs with
the required constructs for the in-seed production of light-chain
devoid simplified SIgAs (sSIgAs) in Arabidopsis (Virdi et al., 2013).
Four different variable domains (named V1, V2, V3 and V4) of
llama heavy chain-only antibodies (VHHs) against enterotoxigenic
Escherichia coli (ETEC) were genetically fused to the Fc part of a
porcine IgA. Upon triple cotransformation with Agrobacterium
cultures bearing T-DNAs with one of the four VHH-IgA fusions,
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the J-chain and the SC, each driven by the seed-specific b-
phaseolin promoter, transformants producing sSIgA in seeds were
identified. This strategy was much faster than the sequential
crossing method, but the frequency with which triple cotrans-
formants were obtained was about 1% of that for obtaining the
single T-DNA transformants. Later, X-ray crystallography revealed
that V1 and V2 bind to the same epitope, whereas V3 binds to
another conformational epitope (Moonens et al., 2015). More-
over, V3 and V4 most likely bind the same epitope because they
differ by a single amino acid (Virdi et al., 2013).
In comparison with a monomeric protein, the production of a
recombinant hetero-multimeric protein requires the appropriate
contribution of several transgenes and their simultaneous trans-
formation into the expression system (organism). Which trans-
formation strategy to follow for the production of complex
hetero-multimeric proteins such as sSIgAs depends on several
parameters such as time, desired protein expression level, tissue
specificity and/or number of available selection markers. At first
sight, cloning all the different sSIgA components in a single T-
DNA seems to be the most straightforward strategy. However, as
the cloning process can be challenging because of the large size
of the construct (about 20 kb), cotransformation seems to be a
good alternative. On the other hand, sequential crossing allows a
step-by-step screening for transformants with the best expression
for each T-DNA, but can be labour intensive because of the need
to screen for double and triple homozygotes. Thus, when the aim
is to produce complex hetero-multimeric proteins in long-life-
cycle plants, the proper choice of the transformation strategy
plays a pivotal role in determining the feasibility of the project.
Here, we compared these three above-mentioned strategies
with a sequential transformation strategy (Figure 1), and evalu-
ated the straightforwardness to obtain plants with high sSIgA
accumulation levels. We used the V2 and V3 VHH-IgA variants
against ETEC developed by us previously (Virdi et al. 2013) and
Arabidopsis as the perfect model to test the stable production of
complex hetero-multimeric proteins in plants because of its short
life cycle. As such, we wanted to pinpoint the advantages and
drawbacks for each of the strategies, and which transformation
method to choose for the production of a SIgA and alike hetero-
multimeric protein in plants.
Results
Cloning of the sSIgA-encoding components
To evaluate these alternative transformation strategies for sSIgA
production in stably transformed Arabidopsis plants, different
T-DNA constructs were assembled, containing the three trans-
genes (i.e. VHH-IgA, J-chain and SC) required for sSIgA
production in one T-DNA or in two different T-DNAs (Figure S1).
Previously, we have designed four different VHH-IgA antibodies
against ETEC and expressed them in A. thaliana seeds to
enable oral passive immunization of weaned piglets by adding
them to the feed (Virdi et al., 2013). Here, we included two of
them, V2 and V3, in the cloning and subsequent plant
transformations to evaluate the reproducibility of our results.
The J-chain, SC and VHH-IgA encoding sequences were each
fused with the N-terminal 2S2 signal peptide and the C-
terminal KDEL motif sequences for ER targeting and retention,
respectively. The coding sequences were transcriptionally con-
trolled by the 50 b phaseolin (1475-bp) promoter and the 30
arceline (600-bp) terminator to obtain seed-specific expression
(Morandini et al., 2011) like in our previous study, so we could
use the best sSIgA producer for the V2 and V3 variant
obtained after triple cotransformation by Virdi et al. (2013) as
reference seed stocks.
For the single T-DNA transformation strategy (Figure 1a), these
three sSIgA expression cassettes were cloned in tandem (same
transcriptional orientation) in a single T-DNA construct (MX-JSA,
Figure S1a). By restriction characterization of individual E. coli
clones, we found that some of them integrated a double copy of
the VHH-IgA cassette, and because this might result in a positive
dosage effect, we included this “single T-DNA double VHH-IgA”
(MX-JSAA, Figure S1b) construct in the comparative transforma-
tion efficiency analysis. Restriction analysis of the clones also
demonstrated the frequent occurrence of a particular variant with
missing fragments in the expected restriction pattern (Figure S2),
and upon inspection, this corresponded to the loss of the J-chain
expression cassette in the pMX-JSA and pMX-JSAA T-DNA vector
plasmids (Figure S1a,b). These frequently observed deletions
occurred not only upon transformation and establishment of the
clones in E. coli, but also upon propagation of the E. coli and
Agrobacterium clones.
For the other three transformation approaches (Figure 1b–d),
the constant elements, being the J-chain and SC, were clustered
in one T-DNA (MX-JS; Figure S1c), and the variable VHH-IgA,
either V2 or V3, was cloned in the other T-DNA (X-A; Figure S1d).
Once the different T-DNA constructs were obtained and
transferred into Arabidopsis tumefaciens, all transformations
were performed by floral dip in wild-type Col-0 plants as
schematically depicted in Figure 1. T1 transformants were
selected on phosphinothricin and/or kanamycin and grown to
obtain T2 seed stocks, which were then screened for their sSIgA
production level. For the crossing strategy, F2 hybrid seeds were
analysed. For the heritability study, homozygous T3 seeds were
analysed.
Efficiencies of different transformation strategies to
obtain sSIgA-producing plants
If speed is an issue, the only two methods that need a single
transformation step are gene stacking of the components in a
single JSA or JSAA T-DNA and cotransformation of the JS and
VHH-IgA T-DNAs, referred to as JS+A (Figure 1a,b). The efficiency
by which all three transgenes were integrated in a single
transformant, independently of the VHH variant, was recorded
for the two strategies. We obtained four times more transfor-
mants with the single JSA T-DNA [2.38% (1.47) of the T1 seeds]
as compared with double selected JS+A cotransformants [0.52%
(0.36) of the T1 seeds].
In the supertransformation strategy (Figure 1c), two subse-
quent transformations are required to obtain the sSIgA-producing
plants: first single-locus homozygous plants producing either
VHH-IgA or the constant components (J-chain together with the
SC) need to be selected, after which they are supertransformed
with the other T-DNA. Here, we supertransformed the already
available lines with high levels of either the V2 or V3 VHH-IgA
variant (Virdi et al., 2013) with a JS T-DNA containing the J-chain
and SC genes. In this way, 21 supertransformants were obtained
and referred to as JSinA. The efficiency by which the new T-DNA
got integrated in the recombinant plants was 4.38% (1.87).
For the crossing strategy (Figure 1d), 24 transformants with the
JS T-DNA, obtained with a frequency of 1.58% (0.29) in the T1
generation, were selected and expression of the J-chain and SC
was screened by quantification in western blots (Figure S3).
Highly variable levels of J-chain and SC expression were observed
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between the JS transformants, and counter-intuitively, also the
relative levels of J-chain and SC within each transformant were
variable (Figure S3a). However, the J-chain western blot assay
revealed the predicted single band at about 20 kDa, the SC
western blot showed a main band of 75 kDa corresponding to
the glycosylated version (as shown later in the characterization of
sSIgA) and a band at the expected molecular weight of 65 kDa,
corresponding to the non-glycosylated SC. Six transformants
showing predominantly glycosylated SC in their western blot
profile and relatively high expression of both SC and J-chain were
propagated to the T3 generation, and of those, four homozy-
gous, single-locus JS transformants were retained (Figure S3b).
These were then crossed with the same VHH-IgA-producing lines
as used in the supertransformation strategy to obtain sSIgA-
producing hybrid seeds referred to as JSxA. All the F1 hybrids
obtained were resistant to both kanamycin and phosphinothricin,
indicating the successful crossing of the lines.
To summarize (Table 1), 15–23 transformants were obtained
by the single T-DNA (JSA or JSAA) or the cotransformation (JS+A)
strategies for both the V2 and V3 variants. In the sequential
transformation strategy, 21 JS supertransformants of the VHH-
IgA expressing lines V2 and V3 were selected (JSinA), and for the
crossing strategy, four hybrid F2 progeny seed stocks (JSxA) were
obtained by crossing the V2 or V3 VHH-IgA-expressing line with
the four best selected events from 24 JS transformants.
sSIgA levels in seeds obtained by different
transformation strategies
The relative amounts of sSIgA recombinant protein production
were determined by an sSIgA-specific ELISA (Figure S4a), in which
only the antigen-binding, fully assembled sSIgAs are measured by
detecting the complex with SC-specific antibodies, while the
antigen-binding VHH-IgA levels present as monomeric, dimeric
and secretory IgAs were determined by a VHH-IgA-specific ELISA
(Figure S4b).
First, the levels of antigen-binding sSIgA in seed extracts from
transformants belonging to the different transformation groups
were compared with those in reference seed stocks for the V2
and V3 variant, producing both VHH-IgA antibodies to levels of
0.2% of seed weight and selected as the best sSIgA producers
after triple cotransformation by Virdi et al. (2013). Because sSIgAs
could not be purified from a mixture of monomeric, dimeric and
secretory IgAs, it prevented us from performing absolute quan-
tifications of the sSIgA content. Conversely, the relative quantifi-
cation of the sSIgA content allowed us to determine the
proportion of transformants in each transformation series that
surpassed the sSIgA content of the reference seed stock. The
proportion of V2 sSIgA transformants accumulating more sSIgAs
than the reference was 33% for the JSA single T-DNA, 30% for
the JSAA single T-DNA, 47% for the JS+A cotransformation, 76%
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Figure 1 Different strategies evaluated for sSIgA
production in Arabidopsis thaliana. In a first round
of transformation (①), T-DNAs MX-JSA, MX-JS
and/or X-A were introduced in wild-type Col-0
Arabidopsis plants via Arabidopsis tumefaciens-
mediated transformation. In the single T-DNA (a)
and cotransformation (b) strategies, no further
transformation was required. In the
supertransformation strategy (c), a second round
(②) of plant manipulation was used to introduce
the MX-JS plasmid in a plant producing VHH-IgA.
In the parallel transformation and crossing
strategy (d), a JS-transformed line and a VHH-IgA-
transformed lined were crossed. Wild-type
Arabidopsis plants are depicted with the image of
an Arabidopsis plant, while transformed
transformants are indicated by representing the T-
DNA on top of the plant. Bar, phosphinothricin
herbicide resistance gene; Kan, kanamycin
resistance gene; J, joining chain; SC, secretory
component; MX, multiple gene expression vector;
X, gene expression vector.
Table 1 Number (No.) of T2 transformants or F2 hybrids obtained for
protein expression analysis and proportion (%) of them unable to
assemble sSIgA despite of showing good VHH-IgA accumulation
levels, per transformation group and type of VHH-IgA (V2 or V3).
Transformation group
V2 V3
No. % No. %
JSA 21 14% 21 29%
JSAA 23 43% 21 29%
JS+A 15 0% 21 0%
JSinA 21 0% 21 0%
JSxA 4 0% 4 0%
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for the JSinA supertransformation and 100% for the hybrids
obtained by crossing (Figure 2a). The same trend was seen for the
V3 sSIgA transformants: 14%, 29%, 29%, 57% and 100% for
JSA, JSAA, JS+A, JSinA, and JSxA, respectively (Figure 2b). Thus,
the supertransformation and crossing strategies provided clearly
the largest proportion of highly producing sSIgA transformants.
Among these, only the crossing strategy of selected events
resulted in a low coefficient of variation (CV) for sSIgA produc-
tion.
Second, the accumulation of antigen binding VHH-IgA was
determined in all V2 and V3 sSIgA transformants, independent of
whether it was present in a monomeric, dimeric or assembled
secretory format. For both the single T-DNA and cotransforma-
tion approaches (JSA, JSAA and JS+A), a large variability in
antigen-binding VHH-IgA accumulation levels could be observed
(Figure 2c,d). The results show that in some groups of transfor-
mants, a positive correlation with the sSIgA and VHH-IgA levels
could be seen, like such as in the group of JSA(V2) transformants,
but in other groups of transformants, there was no correlation
with the levels of sSIgA and VHH-IgA, such as in the JSAA(V3)
group (Figure S5). This indicates that the levels of either of the
three components can be limiting to obtain high sSIgA levels.
Furthermore, and remarkably, a rather high percentage of up to
43% of the single T-DNA transformants (JSA and JSAA) did not
contain detectable amounts of assembled sSIgA (Table 1),
whereas they did almost all contain antigen-binding VHH-IgA
(Figure 2c,d). In contrast, all of the analysed seed extracts from
JS+A or JSinA transformants expressing detectable levels of VHH-
IgA, produced also the assembled sSIgA in variable amounts. In
comparison with the JSA and JS+A obtained seed stocks, the
VHH-IgA accumulation levels in supertransformed JSinA and JSxA
crossed seed stocks were much more similar in the V2 variant, as
pointed by their coefficient of variation (CV) (Figure 2c). A similar
pattern was seen for the V3 VHH-IgA levels, except for the JSinA
transformants that experienced a moderate increase in the CV as
compared with the V2 (Figure 2d).
Then, the four best sSIgA-accumulating transformants from
each strategy were chosen and the relative accumulation of sSIgA
was compared in an ELISA titration experiment. We found that
the V2 sSIgA accumulation levels ranged, on average, from more
than double to almost 32-fold higher than the reference line
(Figure 2e). More specifically, the best JSA and JSAA transfor-
mants contained two- to fourfold more sSIgA accumulation than
the reference line. For the JS+A cotransformants, the sSIgA levels
were about eightfold higher, and among the JSinA supertrans-
formants and JSxA hybrids almost 32-fold higher sSIgA levels
were found. Outliers from the supertransformation and crossing
strategies even contained 64-fold higher sSIgA levels than the
reference line. Similar results were obtained for the four best V3
sSIgA expressors. In this case however, JSA and JSAA transfor-
mants reached slightly better accumulation levels (between four-
to eight-fold difference than the reference) and differences were
not always statistically significant between these groups and the
JSinA and JSxA transformants (Figure 2f).
Molecular characterization of sSIgA-expressing plants
The seed extracts of the best sSIgA transformants in each strategy
were further analysed in different western blot setups. After
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) of the seed extracts in reducing conditions, SC-specific
antibodies revealed a band at about 65 kDa corresponding to a
non-glycosylated form of SC and higher bands corresponding to
glycoforms (Figure 3a) as shown by a PNGase F digest (Figure S6).
Similar blots revealed the presence of the J-chain (Figure 3b) and
the single polypeptide VHH-IgA and proteolysed version of it
(Figure 3c). Quantifying the SC, J-chain and VHH-IgA signals after
SDS-PAGE in reducing conditions further revealed that there was
no clear correlation between the sSIgA amounts as found by
ELISA (Figure 2e,f) and the accumulation levels of either the SC, J-
chain or VHH-IgA component (Figure 3a–c).
Further, we attempted to demonstrate the presence of assem-
bled sSIgA complexes by SDS-PAGE in non-reducing conditions
(Figure 3d–f). We postulate that the faint band at ~250 kDa
corresponds to covalently linked sSIgA complexes of four VHH-Fc
polypeptides, one J-chain and one SC. For most samples, the blots
showed similar relative amounts of assembled sSIgA as found in the
sSIgA-specific ELISA (Figure 2e,f). Discrepancies found in the band
intensities between ELISA and western blot could be attributed to
the likely presence of functional, non-covalently-linked sSIgA,
which is detectable by ELISA but disaggregated during the western
blot procedure, and to the normalisation process applied to the OD
values in the ELISA. Nevertheless, the high proportion of SC, J-chain
and VHH-IgA found in other forms than in the sSIgA complexes is
remarkable. For instance, apart from complexed with sSIgA, SC
could be found as single polypeptide and as a postulated dimer in
different glycoforms (Figure 3d). This was different for the J-chain:
in reducing conditions, the J-chain was present at the expected
molecular weight (Figure 3b), but in non-reducing conditions, the
J-chains were detected in high-molecular weight complexes,
covalently linked among themselves or with antibody chains or
with endogenous proteins, while no free J-chain molecules were
detectable (Figure 3e). Finally, the VHH-IgA main bands corre-
sponded to monomeric and single VHH-IgA polypeptides and
truncated or glycosylated versions of these molecules (Figure 3f).
Differences in the level of glycosylation and proteolysis of the
analysed molecules were observed between transformants, how-
ever, no specific patterns could be assigned to any specific group.
Heritability of sSIgA production
To check the heritability of the expression, we compared the V2
and V3 sSIgA amounts in some segregating T2 seed stocks and
their homozygous T3 progeny (Figure 4). Overall, the production
of sSIgA in T2 and T3 seed stocks was comparable, except for
several transformants in the JSAA series. In these T3 progeny seed
stocks, both for the V2 and V3 series, the sSIgA amounts were
decreased below 50% of the levels achieved by their parents.
Thus, only when the three constructs were cloned in tandem in a
single T-DNA, they seemed more susceptible to gene silencing in
subsequent generations, but we did not confirm this at the
molecular level.
Discussion
The transformation process to produce a hetero-multimeric
protein can follow different paths, leading to certain advantages
and disadvantages related to workload, protein production level
or transformation efficiency, among other parameters. To test
this, we used sSIgA as model. Previously, Virdi et al. (2013) cloned
the three encoding genes (J-chain, SC and VHH-IgA) in three
different T-DNA vectors, and transformants were obtained by
triple cotransformation. Here, we evaluated four alternative
strategies for the stable seed-based production of sSIgA: a JSA
single T-DNA transformation, cotransformation of the JS and
VHH-IgA T-DNAs, supertransformation of a selected VHH-IgA
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transformant with the JS T-DNA and crossing of selected JS and
VHH-IgA transformants. Table 2 summarizes the main advan-
tages and disadvantages encountered for each strategy.
In terms of complexity, the DNA assembly and cloning of the
three components in a single T-DNA vector turned out to be very
difficult, because this T-DNA vector is close to 20 kb, resulting in
very low cloning efficiencies. Combining the genes for J-chain
and SC in one JS T-DNA and the other VHH-IgA component in
another T-DNA, made the cloning process much easier. Another
important factor to consider when introducing multiple genes is
to determine if a number of the genes can be reused to produce
families of heteromeric proteins. For instance, in our sSIgA model,
the J-chain and SC remain constant within the same species,
while only the VHH-IgA differs for every different epitope
(Janeway et al., 2001). Therefore, the reusability of the same J-
chain and SC to produce different SIgAs allows a simplification of
the system by joining both expression cassettes (J-chain and SC) in
a single T-DNA to use in a double cotransformation process
(together with a VHH-IgA bearing plasmid) or to get a stably
transformed JS line producing the J-chain and SC, which
subsequently can be supertransformed with a VHH-IgA bearing
plasmid or crossed with a VHH-IgA-producing plant. Thus, plants
with good expression of the constant elements can be reused in
future projects with different VHH-IgAs, whereas applying the
single T-DNA strategy implies that a new 20-kb construct needs
to be generated for each new VHH. Alternatively, the use of
emerging cloning systems such as Golden Braid (Vazquez-Vilar
et al., 2017) or MoClo (Weber et al., 2011), both based on
Golden Gate multiple assembly technology, may ease the
assembly of huge constructs.
Another problem we encountered was the loss of the J-chain
expression cassette during clone establishment and propagation.
These deletions are most likely the result of homologous
recombination between the repetitive sequences flanking the
different genes. Indeed, as a consequence of using identical
transcriptional regulatory sequences, the three or four genes in
the pMX-JSA and pMX-JSAA constructs, respectively, are flanked
with stretches of more than 1400-bp homology, and even in low-
recombination E. coli strains such as DH5a, these deletions were
observed, as previously described (Bzymek and Lovett, 2001). This
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Figure 2 Relative ELISA-based quantification of
sSIgA and VHH-IgA in seed extracts. Relative sSIgA
content (a and b) and relative antigen-binding
VHH-IgA content (c and d) in transformants
obtained by different transformation strategies,
for the V2 (left) and V3 (right) VHH-IgA variants.
The plotted OD values obtained for each
transformant at a specific dilution in a sSIgA-
specific and a VHH-IgA-specific ELISA,
respectively, were normalized using a reference
(R) extract made from the best sSIgA-producing
lines obtained by Virdi et al. (2013) (sV2A8 for the
V2 and sV3A40 for the V3 variant). The
percentage of transformants that surpassed the
reference sample (represented by a dashed line) in
sSIgA or VHH-IgA accumulation (Surpass R), the
coefficient of variation (CV) and the number of
transformants analysed (No. events) are indicated
below each group. The samples that were further
characterized by Western blot (Figure 3) are
indicated with an arrow. (e and f) Comparison of
the sSIgA levels from each transformation strategy
by a titration experiment. Each bar represents the
average relative sSIgA level of the four highest
sSIgA-accumulating transformants for each
strategy as compared with the reference. The Y-
axis represents the dilution value by which the OD
of a specific sample goes below the threshold, first
calculated as a log2 value (SEM) and then
transformed into relative units compared with the
dilution value recorded for the reference (19).
Error bars represent standard error of the mean.
Statistical significance was evaluated by T-test.
*P < 0.05; **P < 0.01.
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results in bacterial cultures with a mixed population of correct and
truncated versions of the desired T-DNA. Even though cultures
were checked via restriction digestion before plant transforma-
tion, the occurrence of plants producing high concentrations of
VHH-IgA but no detectable levels of sSIgA suggests that these
plants received a truncated version of the T-DNA. These plants
had to be discarded, resulting in a waste of time and resources.
However, previous groups producing SIgA via the single T-DNA
method did not experience homologous recombination in their
constructs (Ariaans et al., 2014; Juarez et al., 2013), and other
groups, such as Ruiz-Lopez et al. (2015) and Malik et al. (2015),
managed to assemble up to six and four expression cassettes,
respectively, without apparent complications. This suggests that
the regulatory sequences used in this project favour the occur-
rence of recombination events. To lower the risk of homologous
recombination, it is possible to work with a pool of different
promotor and terminator sequences. DNA cloning systems such
as Biobricks or GoldenBraid are specially designed for that
purpose, and they allow to choose a la carte between a collection
of promoters and terminators and combine them at will (Smolke,
2009; Vazquez-Vilar et al., 2017). However, care has to be taken
that these different transcriptional regulatory sequences are
synchronised (switched on/off) in the same cells and at the same
time.
Although cloning every gene in separate T-DNA vectors is an
approach that works well for transient expression (Juarez et al.,
2013), for stable transformation, we do not advice to distribute
the genes over more than two T-DNAs because of the time and
screening efforts required. For instance, the transformation
efficiency registered for the triple cotransformation strategy by
Virdi et al. (2013) (0.028%) was approximately 100-fold lower
as compared with the efficiencies achieved by introducing a
single T-DNA at a time (supertransformation and single T-DNA
strategies) and 20-fold lower than that obtained by double
cotransformation. Logically, the efficiency to obtain cotransfor-
mants after A. tumefaciens-mediated transformation is inversely
proportional to the number of different T-DNAs that are
required to integrate and varies depending on the plant species
and target plant tissues (De Buck et al., 2000, 2009). The direct
consequence of obtaining a lower number of cotransformants is
the higher number of transformation projects that need to be
started. In this project with Arabidopsis, a fourfold reduction in
obtaining the desired transformants, when comparing the
double cotransformation to the single T-DNA strategies, is not
an issue, but would be a serious limitation in plants recalcitrant
to transformation (Birch, 1997). It should also be noted here
that every T-DNA commonly requires a different selection
marker. However, a single T-DNA needs only one selection
marker, cotransformation and supertransformation require two
selection markers.
Another point to consider is the time required to obtain sSIgA-
producing plants: whereas the single T-DNA and cotransforma-
tion methods can give sSIgA-producing plants in one plant
transformation cycle, supertransformation and crossing require a
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Figure 3 Western blot characterization of the
selected transformants for each transformation
strategy. Detection of SC (a and d), J-chain (b and
e) and VHH-IgA (c and f) in a western blot after
reducing (+) and non-reducing () PAGE. The
main bands, indicated with a number, most likely
correspond with SC in different glycosylated
forms (1), a postulated dimeric SC (2), the
assembled sSIgA complex (3), J-chain (4), a single
polypeptide of VHH-IgA (5) and truncated versions
thereof (6), assembled simplified mIgA (7) and a
truncated version of the mIgA (8).
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first cycle to obtain stably transformed plants, and a second cycle
for supertransformation or crossing. This extra cycle thus results in
a substantial increase in time and efforts required to obtain the
desired sSIgA-recombinant plants. Taking into account that
cloning a single T-DNA with several constructs takes more time
than cloning simple T-DNA vectors, we conclude that cotrans-
formation is the fastest and least work-demanding option to
obtain transformants producing sSIgA. On top of that, trans-
forming plants such as tobacco and soybean may ease biomass
upscaling of sSIgA-transformed lines, but it comes at the cost of
longer life cycles and more demanding tissue culture require-
ments to obtain the transformants. For instance, Ma et al. (1995)
could stably produce up to 500 lg of SIgA per gram of fresh
weight in the easy-to-scale tobacco leaves, however the process
required (i.e. the sequential crossing of four transgenic tobacco
plants) implied years of work until the first plant producing SIgA
was obtained. On the other side, in plant species such as
duckweed, in which a transformation process takes only a few
weeks (Yamamoto et al., 2001), Ariaans et al. (2014) reached an
SIgA production level of 16% of the total soluble leaf protein by
transforming all the constructs in a single T-DNA.
By determining the assembled sSIgA levels by ELISA and
Western blot analysis, we were able to determine the variability in
expression within each group and more importantly the number
of high-level sSIgA producers in each group. We found that the
single T-DNA transformants (JSA and JSAA) overall had the lowest
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Figure 4 Heritability of sSIgA accumulation. For
each strategy (JSA, JSAA, JS+A and JSinA), the OD
(450 nm) values at a specific dilution in the sSIgA-
specific ELISA of seed extracts of three to four
selected T2 parents and the derived homozygous
offspring (one to four indicated with grey bars
immediately at the right of the parent indicated in
black) were obtained for the V2 (a) and V3 (b)
VHH-IgA variants. The reference (R) corresponds
to the best sSIgA-producing lines obtained by Virdi
et al. (2013) (sV2A8 for V2 and sV3A40 for V3).
The arrows indicate the T3 progenies that show a
more than 50% reduction of sSIgA levels
compared with the T2 parent.
Table 2 Main advantages and disadvantages of each transformation strategy.
Single T-DNA Double cotransformation Supertransformation
Parallel transformation &
Crossing
Cloning process Demanding Easy Easy Easy
Transformation efficiency High Moderate High High
Plant manipulation steps One One Two (or one†) Two
Time to get T2 sSIgA-accumulating plants Moderate Short Long (or short†) Long
High-level sSIgA producers Few Medium Many Many
Selection markers One Two Two Two
Selection of single-locus events One locus One or two loci Two loci Two loci
Selection of stable lines Easy Easy (if single locus) Easy Demanding
†Depending on whether a stable recombinant plant is available to be supertransformed.
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performance in sSIgA accumulation, followed by cotransforma-
tion that only performed slightly better in one of the two VHH-
IgA variants. The low expression level of the three transgenes
within one T-DNA (JSA) might be due to the triple repeat of the
regulatory elements, making them more sensitive to transcrip-
tional gene silencing and position effects (Matzke and Matzke,
1998). Indeed, adding a second VHH-IgA expression cassette to
the single T-DNA (JSAA) did not provide higher sSIgA levels. On
the contrary, the transformants selected for the highest accumu-
lation of sSIgA suffered a drastic reduction in the assembly levels
of this molecule in the next generation most likely because of
gene silencing effects. It has been described how the transgene
copy number, the transgene expression level and the repetitive
use of DNA sequences increase the occurrence of silencing
(Assaad et al., 1993; Lessard et al., 2002; Matzke and Matzke,
1998). Moreover, the high frequency of silencing in the single
T-DNA transformants might be related to the floral dip transfor-
mation method for which it is known that multiple T-DNA copies
are frequently integrated (De Buck et al., 2009). Thus, using
another transformation method or using a rapid screen for single-
copy T-DNA inserts might improve the expression performance of
transformants with T-DNAs encoding all the components of a
hetero-multimeric protein. On the other hand, the results clearly
demonstrate that supertransformation and parallel transforma-
tion followed by crossing are the best suited strategies to find
excellent sSIgA producers among a limited number of transfor-
mants, most likely because of the independent selection of good
events for both T-DNAs. Indeed, if an optimal event occurs in
about 1 of 20 transformants, then the probability of optimal
expression from both T-DNAs will only be found in 1 of 400
transformants. It is indeed known that transgene expression levels
are variable but also, especially for single-copy inserts, to a high
degree heritable (De Buck et al., 2004). Therefore, after crossing
two parentals with high-expressing transgenes, hybrids with high
sSIgA levels can be obtained, whereas, upon supertransforma-
tion, the first generation transformant is selected and screened
for the best expression, and subsequently the best expressor for
the second T-DNA is selected among the second generation
transformants, increasing the chance to isolate a transformant in
which all transgenes have high expression rates. However, a more
detailed look at the expression level of each component via
western blot revealed that we are far from understanding the
most suitable ratios for the assembly of sSIgA. The western blot
results show how, even in the selected top sSIgA-expressing
seeds, several components are not covalently assembled in a
functional sSIgA. VHH-IgA and SC are also found as single
polypeptides and as dimers in their glycosylated and non-
glycosylated form, truncated versions of VHH-IgA are present as
previously described by Virdi et al. (2013), and the J-chain is
covalently linked into aggregates that might limit the amount of
free J-chains available to form sSIgA. A bibliographic research
showed us how the described effects have been experienced
previously by other authors, such as the proteolysis of IgA
(Nakanishi et al., 2017; Paul et al., 2014; Wieland et al., 2006),
the simultaneous presence of different glycoforms (Juarez et al.,
2013; Wieland et al., 2006) and the proteolysis of the SC (Ma
et al., 1995; Nakanishi et al., 2017), the latter not observed here.
These results emphasize the need to thoroughly study molecule
stability and protein interactions when working with hetero-
multimeric proteins.
Another important aspect is the ease with which stable lines
can be generated from the selected transformants by reaching
homozygosity of the inserted T-DNA(s). This is straightforward if
there is only a single locus involved: then one in four of the
segregating T2 seeds will be homozygous. A single-locus insert is
also frequently found after cotransformation, because cotrans-
formed T-DNAs frequently cointegrate at the same genetic locus
(De Neve et al., 1997). On the other hand, supertransformation
and stacking two events by crossing automatically involves two
genetic loci. However, whereas screening for a double homozy-
gous plant among the progeny of a double hybrid requires
intensive screening, getting double homozygous plants in the
supertransformation strategy is simple if a homozygous plant is
used for supertransformation.
In conclusion, single T-DNA and cotransformation approaches
may represent the fastest options to obtain several transfor-
mants in a screening project. However, cotransformation gives
less problems during DNA cloning, single T-DNA cloning requires
only one selection marker and single-locus homozygous plants
are easy to obtain. On the other hand, supertransformation and
crossing are more time-demanding but show an increased
chance to obtain good sSIgA producers. When the aim is to
generate a production platform for a library of sSIgAs, the best
approach seems to be to first select a good stable, homozygous
line producing high levels of the constant J-chain and SC, and
then to use this line to supertransform with several VHH-IgAs to
finally obtain a homozygous lines producing high levels of
sSIgAs.
In all, our work here gives a clear overview of the advantages
and disadvantages of transformation strategies that can be used
for complex protein production in plants, and this can facilitate
and guide important decisions about how to obtain high
expression of hetero-multimeric proteins in different plant pro-
duction systems.
Experimental procedures
Construction of T-DNAs for in-seed sSIgA expression
All cloning experiments were performed in E. coli DH5a. The
different transgenes required for in-seed sSIgA production are
described in Virdi et al. (2013). Briefly, the fusion VHH-IgA and
the porcine SC expression cassettes were introduced in the
pPhasGW destination vector (Morandini et al., 2011), which has
the nptII gene for kanamycin resistance, resulting in the expres-
sion vector pX-A and pX-S, while the porcine J-chain expression
cassette was contained in the pBm43GW,0 plasmid, which has a
bar gene that confers resistance to phosphinothricin (PPT; Karimi
et al., 2005), to obtain pX-J. The combination of restriction
enzymes XbaI, for pX-S, and AvrII, for pX-J, served to transfer the
SC expression cassette from the original plasmid to pX-J, to
obtain pMX-JS with both transgenes in tandem. Because XbaI
and AvrII are isocaudomers, the resultant sequence lost the
reassembled recognition sites. Then, the same combination of
restriction enzymes was used to transfer the VHH-IgA expression
cassette for the V2 and V3 VHH-IgA variants from the pX-A to the
pMX-JS plasmid, to obtain the pMX-JSA plasmid with all three
components in tandem in a single T-DNA. Unexpectedly, a
plasmid with a double copy of the VHH-IgA expression cassette
(pMX-JSAA) was also found.
Agrobacterium-mediated transformation via floral dip
in A. thaliana
The T-DNA plasmid vectors obtained were transformed into
the Agrobacterium strain C58C1RifR with the helper plasmid
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pMP90 (Koncz and Schell, 1986) via electroporation (Shen
and Forde, 1989). The Agrobacterium strains bearing the
correct plasmids were used for floral dip of Col-0 Arabidopsis
plants, as described in Clough and Bent (1998). Transfor-
mants were selected on Murashige and Skoog agar medium
supplemented with nystatin (50 mg/L), vancomycin (750 mg/
L) and PPT (10 mg/L) and/or kanamycin (50 mg/L), depending
on the selection marker of the plasmids used. Finally, single-
locus T2 transformants were identified and homozygous T3
seed stocks were obtained by segregation analysis as
described previously (De Jaeger et al., 2002) for the heritabil-
ity study.
Characterization of J-chain and SC transformants
The seed protein extraction was performed as described by De
Jaeger et al. (2002). The levels of J-chain and SC in the soluble
extract were determined by SDS-PAGE using 4%–15% Mini-
PROTEAN TGXTM Precast Protein Gels (Biorad, Hercules, CA,
USA) under reducing conditions. Then the proteins were blotted
onto a polyvinylidene difluoride membrane using the Trans-Blot
TurboTM Transfer System (BioRad). The SC was detected with
mouse anti-porcine SC (Thermo Fisher MA1-80544, Waltham,
MA, USA) followed by anti-mouse IgG conjugated to horse-
radish peroxidase (HRP; GE Healthcare GENXA931). The porcine
J-chain was detected with mouse anti-human J-chain (Thermo
Fisher MA1-80527) followed by anti-mouse IgG conjugated to
HRP (GE Healthcare GENXA931, Chicago, IL, USA). Recombinant
proteins were visualized and quantified using the Bio-Rad
ChemiDocTM Imaging System (Bio-Rad) and the Image LabTM
software (Biorad). A PNGase F (New England Biolabs, Ipswich,
MA, USA) glycosidase treatment was performed in some
samples to study the glycosylation state of SC, following the
manufacturer’s instructions.
Crossing to obtain sSIgA-producing hybrids
Four stable, high-accumulating JS transformants were selected as
mother plants to be crossed with the pollen of stably transformed
lines producing the highest level of V2 and V3 VHH-IgA as
isolated by Dr. Virdi (Virdi et al., 2013). After the crossing process,
the F1 hybrids were selected on Murashige and Skoog agar
medium supplemented with PPT (10 mg/L) and kanamycin
(50 mg/L), and were then propagated to harvest the segregating
F2 seeds for subsequent protein analysis.
Characterization of T2 and F2 sSIgA-producing seeds
The levels of antigen-binding antibodies in seed protein extracts
from the T2 and F2 seed stocks were determined by ELISA with
immobilized FaeGac (F4-fimbriae most abundant adhesin). The
wells were incubated with serial dilutions of 1 mg/mL seed
protein extract (commonly 1/10, 1/40, 1/160 and 1/640) made
in 2% skimmed milk in PBS. In the sSIgA-specific ELISA setup,
sSIgA complexes binding to FaeG were detected by using a
mouse anti-porcine SC (Thermo Fisher MA1-80544) followed by
an anti-mouse IgG antibody conjugated to HRP (GE Healthcare
GENXA931). In the VHH-IgA-specific ELISA setup, all different
forms of IgA that bind to FaeG were detected by applying an
anti-pig IgA conjugated to HRP (Biorad AAI40P). TMB (3, 30, 5,
50 tetramethylbenzidine, Sigma) was used as substrate for the
HRP, followed by adding 0.18 M H2SO4 45 min post-incubation
to stop the reaction. Finally, both ELISAs were measured at
450 nm in a VERSAmax ELISA microplate reader (Molecular
Devices). The results were normalized against a reference
provided by Dr. Virdi (Virdi et al., 2013). After the analysis,
the best sSIgA-accumulating transformants were used in a
titration experiment to calculate precisely the relative accumu-
lation of sSIgA. In the assay, the sSIgA-specific ELISA setup was
applied to a broader serial dilution of the samples (1/80, 1/160,
1/320, 1/640, 1/1280, 1/2560, 1/5120 and 1/10240). End point
titres were determined within the threshold of two times the
average of a blank sample and then transformed into relative
units compared to the dilution value recorded for the reference.
The protein seed extracts were also evaluated via western blots
after SDS-PAGE, similar to the evaluation of the JS transformants.
The VHH-IgA and the VHH-IgA-derived complexes were detected
with an anti-pig IgA antibody conjugated to HRP (Biorad AAI40P),
while the same antibodies as used for the sSIgA-specific ELISA
were used for SC detection.
Isolation of stable lines producing sSIgA
The best sSIgA expressors in T2 seed stocks among the JSA, JSAA,
JS+A, and JSinA transformants for both V2- and V3-containing
VHH-IgAs were propagated to the next (T3) generation to obtain
stable lines. To simplify the procedure, a segregation analysis was
applied and only single-locus transformants (i.e. showing a 3:1
ratio of resistant to susceptible transformants) were kept. Analysis
of the T3 offspring of these allowed to identify the homozygous
lines. On the other hand, the F1 hybrids resulting from the
crossing were propagated to F2 seed stocks, but stable lines
based on screening for homozygosity of both loci (1/16) were not
isolated.
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